Article Text

AB0150 Understanding The Role of The IL12/iL35 Balance in Sjögren Syndrome
  1. O. Fogel1,2,
  2. E. Rivière2,
  3. R. Seror3,
  4. G. Nocturne3,
  5. B. Ly2,
  6. S. Boudaoud2,
  7. J.-E. Gottenberg4,
  8. J.-J. Dubost5,
  9. V. Le Guern6,
  10. P. Dieudé7,
  11. P. Chanson3,
  12. J. Nititham8,
  13. K. Taylor8,
  14. L. Criswell8,
  15. X. Mariette3,
  16. C. Miceli-Richard6
  1. 1CHU Purpan, Toulouse
  2. 2Inserm UMR1184
  3. 3CHU Bicetre, Paris
  4. 4CHU Hautepierre, Strasbourg
  5. 5CHU Gabriel Montpied, Clermont-Ferrand
  6. 6Chu Cochin
  7. 7CHU Bichat, Paris, France
  8. 8UCSF, San Francisco, United States


Background Primary Sjögren Syndrome (pSS) is an autoimmune disease mediated by B-cells as evidenced by the occurrence of non-Hodgkin lymphoma mainly involving salivary glands and increased B-cell activation markers in the serum of pSS patients. A type I interferon response is also observed among some patients. However, some mice models and large genetic studies suggest an alternative/coexisting involvement of the Th1 pathway in the pathophysiology of the disease. In fact, polymorphisms of IL-12A, which encodes for IL-12p35, have been associated with pSS1. IL-12p35 subunit is shared by 2 heterodimers, IL-12 and IL-35.

Objectives To confirm the genetic association of IL-12A polymorphism with pSS and to elucidate the involvement of the IL-12/IL-35 balance in pSS through functional studies.

Methods The genetic studies were performed on French pSS from 2 cohorts. Functional studies were performed on sorted monocytes and stimulated ex vivo under inflammatory conditions. Interleukin-12A mRNA, IL-12 and IL-35 proteins were quantified by qRT-PCR for mRNA and by ELISA and multiplex kit respectively for IL-35 and IL-12.

Results We confirmed the association between rs485497 and pSS and found an increased level of IL-12 in sera of pSS patients carrying the risk allele (p=0.016). IL-12 was increased in pSS compared to healthy controls (p=0.0001), especially in patients with a more active disease contrary to IL-35 which was decreased in pSS (p=0.0001). We observed that 99% of patients with high serum levels of IL-35 did not developed lymphoma versus 93% in the group with low IL-35 (p=0.03).

Conclusions Our findings emphasize the involvement of the balance IL-12/IL-35 in the pathogenesis of pSS. Further studies especially on regulatory B-cells and plasma cells as well as in animal models of autoimmune diseases assessing the effect of recombinant IL-35, would help to decipher whether this regulatory cytokine could be of interest for future therapeutic approaches.

  1. Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet. nov 2013;45(11):1284–92

Acknowledgement Année recherche ARS Midi-pyrenées

Disclosure of Interest None declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.